Ludovic Wouters

Chairman of the board

Ludovic Wouters is an entrepreneurial executive with deep experience in the radiopharmaceutical and nuclear medicine industry. He co-founded ANMI (Advanced Nuclear Medicine Ingredients), a Belgian company developing streamlined manufacturing solutions for theranostic radiopharmaceuticals, and led it as CEO. In 2018, ANMI was acquired by Telix Pharmaceuticals, now a global radiopharmaceutical leader. Following the acquisition, Ludovic served as Managing Director of ANMI, Vice President of Corporate Development for Telix Europe and President of Telix’s European operations. Today, he is Co-Founder of Fontem, a deep tech venture studio. There he supports portfolio companies on commercial and go-to-market strategy, with a particular focus on the EU market, and on M&A strategy.